Vendor Insights
The global radiopharmaceuticals market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Some vendors are also adopting inorganic growth strategies such as M&As to remain competitive in the market.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
- Actinium Pharmaceuticals Inc.
- Bayer AG
- Bracco Spa
- BWX Technologies Inc.
- Cardinal Health Inc.
- Curium
- Eckert and Ziegler AG
- Eczacibasi Holding AS
- Fusion Pharmaceuticals Inc.
- General Electric Co.
- Jubilant Pharmova Ltd.
- Lantheus Holdings Inc.
Find additional highlights on the growth strategies adopted by vendors and their product offerings, Read Free Sample Report.
Geographical Market Analysis
During the forecast period, North America will account for 44% of the market's growth. In North America, the primary markets for radiopharmaceuticals are the United States and Canada. The market in this region will grow at a slower rate than the market in Asia.
Over the projected period, rising investment in R&D activities in the healthcare industry, particularly in the US market, would help the radiopharmaceuticals market develop in North America. This market research report includes thorough information on competitor intelligence, marketing gaps, and geographical potential for suppliers, all of which will aid in the development of effective business plans.
Furthermore, countries such as the US, Canada, Germany, UK, and China are expected to emerge as prominent markets for the radiopharmaceuticals market during the forecast period.
Know more about this market's geographical distribution along with the detailed analysis of the top regions. https://www.technavio.com/report/radiopharmaceuticals-market-size-industry-analysis
Key Segment Analysis
During the projected period, the diagnostics segment's radiopharmaceuticals market share will expand significantly. Due to its widespread use in the healthcare industry, the diagnostic application of radiopharmaceuticals led the worldwide radiopharmaceuticals market and is likely to continue to do so during the forecast period.
Radiopharmaceuticals are administered orally or intravenously in medical diagnostics. The radiations from the radiopharmaceuticals are then captured by external detectors such as gamma cameras, which are used to create images. The most frequent radioisotope used in diagnostic nuclear medicine is technetium-99m. During the forecast period, such applications will fuel segment expansion.
View FREE Sample: to know additional highlights and key points on various market segments and their impact in coming years.
Key Market Drivers & Challenges:
One of the major factors driving the radiopharmaceuticals market is the increased prevalence of neurological illnesses. The use of radiopharmaceuticals that are related to chemical molecules allows for the study of a specific physiological cycle. The radiopharmaceutical's market size is predicted to grow due to advantages such as excellent efficacy and non-invasive external monitoring.
Furthermore, radiopharmaceutical drugs may be beneficial in the treatment of a variety of neurological illnesses, including schizophrenia, epilepsy, Alzheimer's disease, and head trauma. Radiopharmaceuticals may play an important role in the diagnosis and treatment of neurological diseases. As a result, as the number of cases with neurological illnesses rises, so will the demand for radiopharmaceutical medications.
However, preparation and dispensing problems associated with radiopharmaceuticals are some of the factors hindering the radiopharmaceutical's market growth.
Download free sample for highlights on market Drivers & Challenges affecting the radiopharmaceuticals market.
Customize Your Report
Don't miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can also help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
Related Reports:
Spasticity Treatment Market by Type and Geography - Forecast and Analysis 2022-2026
Vial Adaptors for Reconstitution Drug Market by Therapeutic Area and Geography - Forecast and Analysis 2022-2026
Radiopharmaceuticals Market Scope |
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 9.9% |
Market growth 2022-2026 |
$ 4.37 billion |
Market structure |
Fragmented |
YoY growth (%) |
9.0 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 44% |
Key consumer countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Actinium Pharmaceuticals Inc., Bayer AG, Bracco Spa, BWX Technologies Inc., Cardinal Health Inc., Curium, Eckert and Ziegler AG, Eczacibasi Holding AS, Fusion Pharmaceuticals Inc., General Electric Co., Jubilant Pharmova Ltd., Lantheus Holdings Inc., Navidea Biopharmaceuticals Inc., NorthStar Medical Radioisotopes LLC, Novartis AG, Radiomedix Inc., Siemens Healthineers AG, Sinotau Pharmaceuticals, Telix Pharmaceuticals Ltd., and The South African Nuclear Energy Corp. SOC Ltd. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Incremental Growth
- Exhibit 07: Executive Summary – Data Table on Incremental Growth
- Exhibit 08: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 09: Parent market
- Exhibit 10: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 11: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 12: Market segments
- 3.4 Market outlook: Forecast for 2021-2026
- Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
- Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
- Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
- 4.1 Five forces summary
- Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
- 4.2 Bargaining power of buyers
- Exhibit 18: Bargaining power of buyers – Impact of key factors in 2021 and 2026
- 4.3 Bargaining power of suppliers
- Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
- 4.4 Threat of new entrants
- Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
- 4.5 Threat of substitutes
- Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
- 4.6 Threat of rivalry
- Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
- 4.7 Market condition
- Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Application
- 5.1 Market segments
- Exhibit 24: Chart on Application - Market share 2021-2026 (%)
- Exhibit 25: Data Table on Application - Market share 2021-2026 (%)
- 5.2 Comparison by Application
- Exhibit 26: Chart on Comparison by Application
- Exhibit 27: Data Table on Comparison by Application
- 5.3 Diagnostics - Market size and forecast 2021-2026
- Exhibit 28: Chart on Diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 29: Data Table on Diagnostics - Market size and forecast 2021-2026 ($ million)
- Exhibit 30: Chart on Diagnostics - Year-over-year growth 2021-2026 (%)
- Exhibit 31: Data Table on Diagnostics - Year-over-year growth 2021-2026 (%)
- 5.4 Therapeutics - Market size and forecast 2021-2026
- Exhibit 32: Chart on Therapeutics - Market size and forecast 2021-2026 ($ million)
- Exhibit 33: Data Table on Therapeutics - Market size and forecast 2021-2026 ($ million)
- Exhibit 34: Chart on Therapeutics - Year-over-year growth 2021-2026 (%)
- Exhibit 35: Data Table on Therapeutics - Year-over-year growth 2021-2026 (%)
- 5.5 Market opportunity by Application
- Exhibit 36: Market opportunity by Application ($ million)
6 Customer Landscape
- 6.1 Customer landscape overview
- Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
- 7.1 Geographic segmentation
- Exhibit 38: Chart on Market share by geography 2021-2026 (%)
- Exhibit 39: Data Table on Market share by geography 2021-2026 (%)
- 7.2 Geographic comparison
- Exhibit 40: Chart on Geographic comparison
- Exhibit 41: Data Table on Geographic comparison
- 7.3 North America - Market size and forecast 2021-2026
- Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
- Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
- Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
- 7.4 Europe - Market size and forecast 2021-2026
- Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
- Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
- Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
- 7.5 Asia - Market size and forecast 2021-2026
- Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
- Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
- Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
- 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
- Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
- Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
- 7.7 US - Market size and forecast 2021-2026
- Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
- Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
- Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
- 7.8 Germany - Market size and forecast 2021-2026
- Exhibit 62: Chart on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 63: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
- Exhibit 64: Chart on Germany - Year-over-year growth 2021-2026 (%)
- Exhibit 65: Data Table on Germany - Year-over-year growth 2021-2026 (%)
- 7.9 UK - Market size and forecast 2021-2026
- Exhibit 66: Chart on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 67: Data Table on UK - Market size and forecast 2021-2026 ($ million)
- Exhibit 68: Chart on UK - Year-over-year growth 2021-2026 (%)
- Exhibit 69: Data Table on UK - Year-over-year growth 2021-2026 (%)
- 7.10 Canada - Market size and forecast 2021-2026
- Exhibit 70: Chart on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 71: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
- Exhibit 72: Chart on Canada - Year-over-year growth 2021-2026 (%)
- Exhibit 73: Data Table on Canada - Year-over-year growth 2021-2026 (%)
- 7.11 China - Market size and forecast 2021-2026
- Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
- Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
- Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
- 7.12 Market opportunity by geography
- Exhibit 78: Market opportunity by geography ($ million)
8 Drivers, Challenges, and Trends
- 8.3 Impact of drivers and challenges
- Exhibit 79: Impact of drivers and challenges in 2021 and 2026
9 Vendor Landscape
- 9.2 Vendor landscape
- Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
- 9.3 Landscape disruption
- Exhibit 81: Overview on factors of disruption
- 9.4 Industry risks
- Exhibit 82: Impact of key risks on business
10 Vendor Analysis
- 10.1 Vendors covered
- Exhibit 83: Vendors covered
- 10.2 Market positioning of vendors
- Exhibit 84: Matrix on vendor position and classification
- 10.3 Bayer AG
- Exhibit 85: Bayer AG - Overview
- Exhibit 86: Bayer AG - Business segments
- Exhibit 87: Bayer AG - Key news
- Exhibit 88: Bayer AG - Key offerings
- Exhibit 89: Bayer AG - Segment focus
- 10.4 Cardinal Health Inc.
- Exhibit 90: Cardinal Health Inc. - Overview
- Exhibit 91: Cardinal Health Inc. - Business segments
- Exhibit 92: Cardinal Health Inc. - Key news
- Exhibit 93: Cardinal Health Inc. - Key offerings
- Exhibit 94: Cardinal Health Inc. - Segment focus
- 10.5 Curium
- Exhibit 95: Curium - Overview
- Exhibit 96: Curium - Product / Service
- Exhibit 97: Curium - Key offerings
- 10.6 Eckert and Ziegler AG
- Exhibit 98: Eckert and Ziegler AG - Overview
- Exhibit 99: Eckert and Ziegler AG - Business segments
- Exhibit 100: Eckert and Ziegler AG - Key news
- Exhibit 101: Eckert and Ziegler AG - Key offerings
- Exhibit 102: Eckert and Ziegler AG - Segment focus
- 10.7 Eczacibasi Holding AS
- Exhibit 103: Eczacibasi Holding AS - Overview
- Exhibit 104: Eczacibasi Holding AS - Product / Service
- Exhibit 105: Eczacibasi Holding AS - Key offerings
- 10.8 General Electric Co.
- Exhibit 106: General Electric Co. - Overview
- Exhibit 107: General Electric Co. - Business segments
- Exhibit 108: General Electric Co. - Key news
- Exhibit 109: General Electric Co. - Key offerings
- Exhibit 110: General Electric Co. - Segment focus
- 10.9 Jubilant Pharmova Ltd.
- Exhibit 111: Jubilant Pharmova Ltd. - Overview
- Exhibit 112: Jubilant Pharmova Ltd. - Business segments
- Exhibit 113: Jubilant Pharmova Ltd. - Key news
- Exhibit 114: Jubilant Pharmova Ltd. - Key offerings
- Exhibit 115: Jubilant Pharmova Ltd. - Segment focus
- 10.10 Lantheus Holdings Inc.
- Exhibit 116: Lantheus Holdings Inc. - Overview
- Exhibit 117: Lantheus Holdings Inc. - Business segments
- Exhibit 118: Lantheus Holdings Inc. - Key offerings
- Exhibit 119: Lantheus Holdings Inc. - Segment focus
- 10.11 Novartis AG
- Exhibit 120: Novartis AG - Overview
- Exhibit 121: Novartis AG - Business segments
- Exhibit 122: Novartis AG - Key offerings
- Exhibit 123: Novartis AG - Segment focus
- 10.12 Siemens Healthineers AG
- Exhibit 124: Siemens Healthineers AG - Overview
- Exhibit 125: Siemens Healthineers AG - Business segments
- Exhibit 126: Siemens Healthineers AG - Key news
- Exhibit 127: Siemens Healthineers AG - Key offerings
- Exhibit 128: Siemens Healthineers AG - Segment focus
11 Appendix
- 11.2 Inclusions and exclusions checklist
- Exhibit 129: Inclusions checklist
- Exhibit 130: Exclusions checklist
- 11.3 Currency conversion rates for US$
- Exhibit 131: Currency conversion rates for US$
- 11.4 Research methodology
- Exhibit 132: Research methodology
- Exhibit 133: Validation techniques employed for market sizing
- Exhibit 134: Information sources
- 11.5 List of abbreviations
- Exhibit 135: List of abbreviations
About Us:
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article